Therefore 74% are positive. Oppenheimer Holdings, Inc. dropped their price target on shares of Envision Healthcare Corporation from $77.00 to $40.00 and set an "outperform" rating for the company in a research report on Thursday. According to these analysts, the Low Revenue Estimate for Envision Healthcare Holdings, Inc.is 1.66 Billion and the High Revenue Estimate is 1.79 Billion. Cantor Fitzgerald maintained the stock with "Buy" rating in Thursday, July 13 report. Of those insider trades, 20,875 shares of Envision Healthcare Corporation were purchased and 0 shares were sold. KeyBanc Capital Markets maintained the stock with "Hold" rating in Monday, October 16 report. The rating was upgraded by Stifel Nicolaus to "Buy" on Friday, November 6.
According to Envision Healthcare Corporation (EVHC) most recent 13F filing, the company has 41 new institutional holders - accounting for 2.57 million shares of its common stock. Cantor Fitzgerald maintained the shares of EVHC in report on Wednesday, October 28 with "Buy" rating.
EVHC has been the subject of several analyst reports. The firm earned "Sell" rating on Tuesday, August 25 by Zacks. Jefferies downgraded Shutterstock Inc (NYSE:SSTK) on Friday, August 7 to "Hold" rating. The Firm is a well-known provider of electrical, industrial and communications maintenance, fix and operating (MRO) and original equipment manufacturers (OEM) products, construction materials, and supply chain management and logistics services. The company was initiated on Friday, December 9 by Goldman Sachs. The rating was maintained by Mizuho on Monday, January 11 with "Neutral". The firm earned "Buy" rating on Thursday, August 3 by Stifel Nicolaus. As per Tuesday, May 30, the company rating was maintained by Mizuho. The Stock has YTD (year to date) performance of -56.94 percent. Its share price has decline -31.61% in three months and is down -8.25% for the last five trades. Wasatch Advisors Inc owns 2.49 million shares or 1.99% of their U.S. portfolio.
Investors sentiment increased to 1.05 in Q2 2017. Its down 0.02, from 0.93 in 2017Q1.
BMO Capital Markets Reaffirms Hold Rating for Valeant Pharmaceuticals International, Inc. (VRX)
Davis Selected Advisers increased its stake in shares of Valeant Pharmaceuticals International by 0.9% in the second quarter. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink .
Old National Bancorp is a financial holding company. Disciplined Growth Investors Inc Mn reported 0.15% in ChannelAdvisor Corp (NYSE:ECOM). Allen Investment Management Limited Company stated it has 5,500 shares. Legal And General Public Limited Co holds 0% of its portfolio in Shutterstock Inc (NYSE:SSTK) for 36,575 shares. BNP Paribas Arbitrage SA raised its stake in shares of Envision Healthcare Corporation by 51.2% during the 3rd quarter. California Public Employees Retirement Systems holds 23,800 shares or 0% of its portfolio. Spark Inv Mngmt accumulated 200,200 shares. Piermont Mngmt, a Missouri-based fund reported 18,670 shares. Douglas Lane & Associates LLC owned approximately 0.09% of Envision Healthcare Corporation worth $4,931,000 as of its most recent filing with the Securities & Exchange Commission. It operates in two segments: EmCare Holdings, Inc. The company has market cap of $2.46 billion. The Company's library of content includes digital imagery, which consists of licensed photographs, vectors, illustrations and video clips that clients use in their visual communications, such as Websites, digital and print marketing materials, corporate communications, books, publications and video content, and commercial music, which consists of music tracks and sound effects and which is often used to complement digital imagery. The P/E Ratio for EVHC is NE. It also offers digital asset management services through its cloud digital asset management platform (webdam).
Envision Healthcare Corporation (NYSE:EVHC) continues to be a formidable company. It has underperformed by 40.01% the S&P500.
The company reported the earnings of $0.36/Share in the last quarter where the estimated EPS by analysts was $0.36/share. They expect $0.83 EPS, down 21.70 % or $0.23 from last year's $1.06 per share. Envision Healthcare Corporation (NYSE:EVHC) has noticeable measure of stock volatility, for this average true range is an exponential moving average (14 trading days) of the True Ranges.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
- Selena to receive star on the Hollywood Walk of Fame
- House Republicans introduce resolution to boot Mueller from Russian Federation probe
- Brokerages Set Dicerna Pharmaceuticals, Inc. (DRNA) PT at $6.08
- Masahiro Tanaka opts in to contract with Yankees
- United States bombers fly over Korean peninsula
- Performance Up Watch on Cabot Oil & Gas Corporation (COG) - stock moves 5.00%
- Ces joueurs d’origine africaine évoluant pour des nations européennes
- Beyonce Pays Homage to Lil Kim in Five Halloween Costumes!
- "Le PSG, c'était chaud..." — Dortmund-Zagadou
- Tata Power Q2 net plunges 44% on Mundra plant loss, one-off impacts